Preparation, characterization and in vitro-in vivo evaluation of bortezomib supermolecular aggregation nanovehicles.
Ontology highlight
ABSTRACT: BACKGROUNDS:Intolerable toxicity and unsatisfactory therapeutic effects are still big problems retarding the use of chemotherapy against cancer. Nano-drug delivery system promised a lot in increasing the patients' compliance and therapeutic efficacy. As a unique nano-carrier, supermolecular aggregation nanovehicle has attracted increasing interests due to the following advantages: announcing drug loading efficacy, pronouncing in vivo performance and simplified production process. METHODS:In this study, the supermolecular aggregation nanovehicle of bortezomib (BTZ) was prepared to treat breast cancer. RESULTS:Although many supermolecular nanovehicles are inclined to disintegrate due to the weak intermolecular interactions among the components, the BTZ supermolecules are satisfying stable. T
SUBMITTER: Chen MY
PROVIDER: S-EPMC7118915 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA